Vaccination may protect against severe Covid-19 for 3 years
The task force estimates that mRNA vaccination provides more immunity to severe Covid-19 than natural infection.
Keystone / Laurent Gillieron
Swiss immunology experts estimate mRNA vaccination could provide more than two times the length of protection against severe Covid-19 infection than natural infection.
This content was published on
2 minutes
swissinfo.ch/jdp
Português
pt
Vacina pode proteger contra Covid-19 severa por 3 anos
In a policyExternal link brief published on Friday, the Swiss National Covid Science Task Force writes that after mRNA vaccination, individuals below 65 years of age likely maintain more than 50% protection against mild infection for 16 months or longer and more than 80% protection against severe infection for more than three years.
This is 3-6 months and 10-12 months more than after natural infection. For the same age group, the scientists estimate that there is 16 months protection from severe disease after natural infection.
In people over 70 years old, the protection is expected to be shorter. The scientists estimate that protection against severe infection may last for up to 2 years.
The estimates use data modelling based on recent scientific evidence on B and T cell responses after vaccination or infection.
The authors caution that these are preliminary estimates that rely on several assumptions and extrapolations of existing data. A true immunologic correlation of protection from SARS-CoV-2 infection has not been identified. The findings may also not be accurate in the face of highly transmissible variants. “Protection against such variants is predicted to be significantly lower and shorter lived,” write the authors.
The protection duration can help inform when booster shots should be given and the length of validity for Covid-19 certificates. Based on the findings, a booster shot for lower risk individuals may not be necessary within two years. For people over 70 years old, a booster may offer benefits if administered within one year.
The scientists also recommend that the sequencing of viral variants is accompanied by monitoring of risk groups for premature reductions in immunity to severe infection.
Popular Stories
More
Banking & Fintech
UBS releases ‘hundreds’ of staff in fresh wave of job cuts
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
This content was published on
The parents of the young jihadist who left for Syria to join the Islamic State have been given suspended sentences by the Federal Criminal Court.
This content was published on
Felix Lehner, Pamela Rosenkranz and Miroslav Sik have been awarded the Swiss Grand Award for Art/Prix Meret Oppenheim 2025.
Nearly 2% of new Swiss disability insurance claims involve Long Covid
This content was published on
Just under 2% of new claims submitted to the disability insurance between 2021 and 2023 concern people suffering from Long Covid.
This content was published on
The watch industry had to contend with a weakening of its exports last year, which reached a volume of CHF25.9 billion ($28.5 billion).
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.